Compare ADIL & EKSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADIL | EKSO |
|---|---|---|
| Founded | 2010 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8M | 7.7M |
| IPO Year | 2018 | N/A |
| Metric | ADIL | EKSO |
|---|---|---|
| Price | $0.30 | $4.42 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $1.50 | ★ $7.75 |
| AVG Volume (30 Days) | ★ 350.0K | 316.3K |
| Earning Date | 11-13-2025 | 10-28-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $14,749,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $54.65 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.22 | $2.73 |
| 52 Week High | $1.30 | $14.97 |
| Indicator | ADIL | EKSO |
|---|---|---|
| Relative Strength Index (RSI) | 41.89 | 48.49 |
| Support Level | $0.30 | $3.50 |
| Resistance Level | $0.33 | $4.51 |
| Average True Range (ATR) | 0.02 | 0.39 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 47.05 | 63.89 |
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.